A TEM-derived extended-spectrum β-lactamase in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 11, 1996, Pages 2488-2493

  Mugnier, P ^a   Dubrous, P ^b   Casin, I ^a,c   Arlet, G ^c   Collatz, E ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PERCY MILITARY HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; SULBACTAM; TAZOBACTAM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; GENE MUTATION; GRAM NEGATIVE INFECTION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0029914147     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.11.2488     Document Type: Article

References (48)

1. Allmansberger, R., B. Bräu, and W. Piepersberg. 1985. Genes for gentamicin-(3)-N-acetyltransferases III and IV. II. Nucleotide sequences of three AAC(3)-III genes and evolutionary aspects. Mol. Gen. Genet. 198:514-520.
2. Ambler, R. P., F. W. Coulson, J.-M. Frere, J.-M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A Standard numbering scheme for class A β-lactamases. Biochem. J. 276:269-272.
3. Arlet, G., G. Brami, D. Décrè, J. L. Flippa, O. Gaillot, P. H. Lagrange, and A. Philippon. 1995. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiol. Lett. 134: 203-208.
4. Billot-Klein, D. Unpublished data.
5. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
6. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
7. Bissonnette, L., and P. H. Roy. 1992. Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria. J. Bacteriol. 174:1248-1257.
8. Black, W. A., and R. W. A. Girdwood. 1969. Carbenicillin resistance in Pseudomonas aeruginosa. Br. Med. J. 4:234.
9. Blazquez, J., M. I. Morosini, M. C. Negri, M. Gonzales-Leiza, and F. Baquero. 1995. Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM β-lactamases. Antimicrob. Agents Chemother. 39:145-149.
10. Bordon-Pallier, F. 1993. Ph.D. thesis. Université Paris XI, Paris.
11. Bradford, M. M. 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilising a principal of protein-dye binding. Anal. Biochem. 72:248-254.
12. Bradford, P. A., N. V. Jacobus, N. Bhachech, and K. Bush. 1995. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 40:260-262.
13. Bradford, P. A., C. Urban, A. Jaiswal, N. Marino, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
14. Brun-Buisson, C., P. Legrand, A. Philippon, F. Montraverse, M. Ansguer, and J. Duval. 1987. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii:302-306.
15. Bush, K., J. S. Freudenberger, and R. B. Sykes. 1982. Interaction of azthreonam and related monobactams with β-lactamases from gram-negative bacteria. Antimicrob. Agents Chemother. 22:414-420.
16. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
17. Cavallo, J. D. Personal communication.
18. Danel, F., L. M. C. Hall, D. Gur, and D. M. Livermore. 1995. OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1881-1884.
19. Danel, F., L. M. C. Hall, D. Gur, and D. M. Livermore. 1995. OXA-2-related β-lactamase giving ceftazidime resistance in P. aeruginosa from Turkey, abstr. C24, p. 43. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
20. Datta, N., and P. Kontomichalou. 1965. Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature (London) 208:239-241.
21. Gutmann, L., B. Ferré, F. W. Goldstein, N. Rizk, E. Pinto-Schuster, J. F. Acar, and E. Collatz. 1989. SHV-5, a novel SHV-type β-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob. Agents Chemother. 33:951-956.
22. Gutmann, L., M. D. Kitzis, D. Billot-Klein, F. Goldstein, G. Tran Van Nhieu, T. Lu, J. Carlet, E. Collatz, and R. Williamson. 1988. Plasmid-mediated β-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev. Infect. Dis. 10:860-866.
23. Hall, R. M., and C. M. Collis. 1995. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol. Microbiol. 15:593-600.
24. Huang, W., Q. Q. Le, M. La Rocco, and T. Palzkill. 1994. Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 β-lactamase. Antimicrob. Agents Chemother. 38:2266-2269.
25. Jacoby, G. A. 1994. Genetics of extended-spectrum β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 1):2-11.
26. Jacoby, G. A., and I. Carreras. 1990. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 34:858-862.
27. Jacoby, G. A., and L. Sutton. 1979. Activity of β-lactam antibiotics against Pseudomonas aeruginosa carrying R plasmids determining different β-lactamases. Antimicrob. Agents Chemother. 16:243-245.
28. King, A., K. Shannon, and I. Phillips. 1980. In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases. Antimicrob. Agents Chemother. 17:165-169.
29. Kitzis, M. D., D. Billot-Klein, F. W. Goldstein, R. Williamson, G. Tran Van Nhieu, J. Carlet, J. F. Acar, and L. Gutmann. 1988. Dissemination of the novel plasmid-mediated β-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-lactamase inhibitors. Antimicrob. Agents Chemother. 32:9-14.
30. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
31. Labia, R., A. Morand, K. Tiwari, J. Sirot, D. Sirot, and A. Petit. 1988. Interactions of new plasmid-mediated β-lactamases with third-generation cephalosporins. Rev. Infect. Dis. 10:885-891.
32. Livermore, D. M., R. J. Williams, and J. D. Williams. 1981. Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, moxalactam and ceftriaxone against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 8:323-331.
33. Livermore, D. M., and Y. Yang. 1987. β-Lactamase lability and inducer power of newer β-lactam antibiotics in relation to their activity against β-lactamase-inducibility mutants of Pseudomonas aeruginosa. J. Infect. Dis. 155:775-782.
34. Lowbury, E. J. L., A. Kidson, H. A. Lilly, G. A. J. Ayliffe, and R. J. Jones. 1969. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet 11:448-452.
35. Matthews, M., and R. W. Hedges. 1976. Analytical isoelectric focusing of R factor-determined β-lactamases: correlation with plasmid compatibility. J. Bacteriol. 125:713-718.
36. Mugnier, P., I. Podglajen, L. Gutmann, and E. Collatz. 1994. Cloning and nucleotide sequence analysis of two Pseudomonas aeruginosa genes encoding the novel OXA-type β-lactamase variants OXA-12 and OXA-13, susceptible to inhibition by imipenem, abstr. C98, p. 139. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
37. Nordmann, P., and T. Naas. 1994. Sequence analysis of PER-1 extended-spectrum β-lactamase from Pseudomonas aeruginosa and comparison with class A β-lactamases. Antimicrob. Agents Chemother. 38:104-114.
38. Nordmann, P., E. Ronco, T. Naas, C. Duport, Y. Michel-Briand, and R. Labia. 1993. Characterization of a novel extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 37:962-969.
39. Palzkill, T., and D. Botstein. 1992. Probing β-lactamase structure and function using random replacement mutagenesis. Proteins 14:29-44.
40. Péduzzi, J., M. Barthélémy, K. Tiwari, D. Mattioni, and R. Labia. 1989. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 β-lactamase. Antimicrob. Agents Chemother. 33:2160-2163.
41. Rice, L. B., L. L. Carias, R. A. Bonomo, and D. M. Shlaes. 1996. Molecular genetics to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy. J. Infect. Dis. 173:151-158.
42. Shaw, K. J., P. N. Rather, R. S. Hare, and G. H. Miller. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.
43. Stemmer, W. P. C. 1994. Rapid evolution of a protein in vitro by DNA shuffling. Nature (London) 370:389-391.
44. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
45. Thompson, R. 1986. R plasmid transfer. J. Antimicrob. Chemother. 18(Suppl. C):13-23.
46. Tran Van Nhieu, G., and E. Collatz. 1987. Primary structure of an aminoglycoside 6′-N-acetyltransferase, AAC(6′)-4, fused in vivo with the signal peptide of the Tn3-encoded β-lactamase. J. Bacteriol. 169:5708-5714.
47. Venkatachalam, K. V., W. Huang, M. LaRocco, and T. Palzkill. 1994. Characterization of TEM-1 β-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidimc. J. Biol. Chem. 269:23444-23450.
48. Zhou, X. Y., F. Bordon, D. Sirot, M. D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.